Skip to content
healthcare.dev
Get a free key

JET ALERT Double Strength

NDC 15579-200, Caffine, tablet, coated, from Bell Pharmaceuticals, Inc.

Product NDC
15579-200
Status
Listed
Labeler
Bell Pharmaceuticals, Inc
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M011
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15579-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE200 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
15579-200-16155790200161 BOTTLE in 1 CARTON (15579-200-16) / 90 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 15579-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15579-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15579-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.